Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study
BJU International · 2025
DOI: 10.1111/bju.16735 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift BJU International, 2025. Verfasst von Karin Olsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional Cancer Centre Stockholm-Gotland, Region Stockholm ALF Funding.
Abstract (Originalsprache)
Objectives
To investigate men's experiences of undergoing the diagnostic pathway within the Swedish Organised Prostate Cancer Testing (OPT) programme in Stockholm County. Subjects and methods The OPT in Sweden is a structured programme aimed at reducing unnecessary medical interventions while ensuring early detection. Men in selected age groups receive an invitation, including information on the benefits and risks of prostate‐specific antigen (PSA) testing. Those with PSA levels above a pre‐defined threshold ( ≥ 3 ng/mL) are referred for magnetic resonance imaging (MRI) to assess the need for further evaluation. If MRI indicates a biopsy is needed, men are referred to urology for targeted and/or systematic biopsy. To explore men's experiences with the diagnostic pathway of the OPT, semi‐structured interviews were conducted with 22 participants in Stockholm County. Thematic analysis was used to identify, analyse, and describe patterns within the data.
Results
After their initial PSA test, informants expressed a need for more guidance in interpreting their test results. At the MRI stage, they requested clearer information, as it requires preparations that could otherwise be overlooked. For the biopsy, informants desired more support before and after the procedure, as it can trigger fear and anxiety. Overall, they perceived the diagnostic pathway as efficient but too automated. They requested more personalised information and support, especially towards the end of the process.
Conclusion
This study shows that the OPT programme was well received by participating men; however, they requested more personalised information and support throughout the process. These needs increased further along the diagnostic pathway as the examinations became more invasive and the risk of detecting prostate cancer increased. Patient perspectives need to be considered to improve this programme and similar programmes in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.
- Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
- Regional Cancer Centre Stockholm Gotland, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Sara Delilovic
Förderung
- Regional Cancer Centre Stockholm-Gotland
- Region Stockholm ALF Funding
Zitieren
APA
Olsson, K., Delilovic, S., Enelius, M. B., Hägglund, A., Lantz, A., & Richter, A. (2025). Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study. BJU International. https://doi.org/10.1111/bju.16735
Vancouver
Olsson K, Delilovic S, Enelius MB, Hägglund A, Lantz A, Richter A. Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study. BJU International. 2025. doi:10.1111/bju.16735
BibTeX
@article{Olsson2025,
author = {Olsson, Karin and Delilovic, Sara and Enelius, Moa Backman and Hägglund, Anna and Lantz, Anna and Richter, Anne},
title = {Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16735}
}
EUVIMED